Resource for professionals in the BioResearch industry- Information on BioPharm Contract Manufacturing, BioPharm Processing, BioResearch Technology, BioPharm Manufacturing, Mixing
Home  |  Buy Online  |  Sell Online  |  Services  |  News & Community Sign In  |  Tools  |  Help
LaureatePharma
About Us     
Laureate Pharma, a full service contract manufacturing company located in Princeton, New Jersey, provides specialized services from process design and development to full-scale current Good Manufacturing Practices (cGMP) production, purification, aseptic filling, testing, validation, analytical services and regulatory support. Our experienced scientists purify biopharmaceutical proteins, expressed in mammalian cells, using state-of-the-art semi-automated chromatography systems and fill into vials under stringent aseptic conditions. Our contract manufacturing expertise spans the area of clinical to commercial-scale production of monoclonal antibodies, interleukins, enzymes, antibody conjugates and radiolabeled antibodies.

Laureate Pharma offers a proven, fully integrated cGMP facility staffed with experts and specialists in each critical area. The management and staff combine the unique experience and capabilities of manufacturing both clinical-trial and commercial scale biopharmaceuticals for over 20 years. We have a proven track record of taking products through development and manufacturing to the market. We focus on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products.

Our 57,000 sq.ft. (5,300m2) facility in Princeton, New Jersey, includes development laboratories and manufacturing areas that house both hollow-fiber and stirred-tank bioreactors, ranging from 20 to 2,500L in size. Laureate Pharma’s assets include multiple stirred tanks, wave systems and hollow fiber bioreactors. We validate critical equipment and processes for the production of biopharmaceuticals, and the regulatory agencies routinely inspect our facilities.

We offer aseptic fill and finish services to formulate and fill the final product. Our facility features a specialized high precision filling machine with minimal holdup volume and whose product contact parts are all single use disposable. It operates within a class 100 filling area and can accommodate vials from 2-100 mL in size, with fill volumes from 0.1 - 100 mL. This equipment can accommodate batch sizes up to 20,000 vials or 200 liters of bulk volume. We perform Formulation development, QC testing, Media fills with product-specific components, Container-closure studies, SOPs and documentation systems and Full ISO environmental monitoring.

Our Quality System consists of Quality Control (QC), Quality Assurance (QA), Microbiology and Validation. The integration of all these functional operations ensures compliance at every step of the cGMP and manufacturing process. The Quality System department works closely with manufacturing groups to assure adherence to quality standards in all systems and processes throughout Laureate Pharma’s facilities.



Send This Page To An Associate

Request More Information
Visit Our Web Site
Email Us

Contact Information     
Laureate Pharma
201 College Road East
Princeton, New Jersey 08540
UNITED STATES
Phone: 609-919-3300
Contact: Yamuna Dasarathy

Hot Products     
AccelerateYourBioPharm.jpg
Upstream Processing
Downstream Processing
Aseptic Fill/Finish
Preclinical Production
Biopharmaceutical Capabilities
Quality Systems
Expertise and Experience

Featured Articles     
Laureate Pharma Announces Agreement With Tolera Therapeutics
Laureate Pharma To Manufacture Tolerx TRX518 Antibody, Used As Cancer Indicator
Laureate Pharma Adds More Manufacturing Capacity
Laureate Pharma Presents Best Practices In Manufacturing Fusion Proteins At The September 2008 Bioprocess International Conference
Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
Laureate Announces Second Manufacturing Agreement With Cytheris
Laureate Pharma Reports Record Growth For 2007
Laureate Announces Manufacturing Agreement With Arius For Top-2 Targeting Antibody
Laureate Pharma Appoints Gary Swan As Vice President Of Operations
Single-Use Technologies - A Contract Biomanufacturer's Perspective
cGMP Production Of Antibodies – From A Vial Of Cells To Bioreactor cGMP Scale-up
Laureate Announces Manufacturing Agreement With ARIUS For Trop-2 Targeting Antibody
Laureate Pharma Announces Agreement With ImmunoGen
Laureate Pharma Recognizes 178% Revenue Growth Year-Over-Year; EBITDA Positive For The Second Quarter 2007
Laureate Pharma Announces Agreement With Enobia Pharma, Inc.
Laureate Pharma Announces Agreement With Trubion Pharmaceuticals


Bioresearch Online  |   VertMarkets, Inc.  |   Contact Bioresearch Online
Legal  |   Help  |   Privacy Statement
Copyright © 1996-2008, VertMarkets, Inc. All rights reserved.